FIRST RESULTS OF INTRAVENOUS APPLICATION OF BISPECIFIC ANTIBODY (CD3 CD19 SHR-1) TO PATIENTS WITH CD19 POSITIVE B-CELL MALIGNANCIES - A PHASE-1 STUDY/

Authors
VANHOUTEN AA HAAGEN IA CLARK M GEERARS A DELAU W BAST EJEG DEGAST GC
Citation
Aa. Vanhouten et al., FIRST RESULTS OF INTRAVENOUS APPLICATION OF BISPECIFIC ANTIBODY (CD3 CD19 SHR-1) TO PATIENTS WITH CD19 POSITIVE B-CELL MALIGNANCIES - A PHASE-1 STUDY/, Experimental hematology, 21(8), 1993, pp. 1120-1120
Citations number
NO
Categorie Soggetti
Medicine, Research & Experimental",Hematology
Journal title
Experimental hematology → ACNP
ISSN journal
0301472X
Volume
21
Issue
8
Year of publication
1993
Pages
1120 - 1120
Database
ISI
SICI code
0301-472X(1993)21:8<1120:FROIAO>2.0.ZU;2-3